.Pharmacolibrary.Drugs.V_Various.V09G_CardiovascularSystem.V09GA06_Technetium99mtcStannousA.Technetium99mtcStannousA .Pharmacolibrary.Drugs.V_Various.V09G_CardiovascularSystem.V09GA06_Technetium99mtcStannousA.Technetium99mtcStannousA| name: | Technetium99mtcStannousAgentLabelledCells | |
| ATC code: | V09GA06 | route: | intravenous |
| compartments: | 1 | |
| dosage: | 20 | mg |
| volume of distribution: | 4.5 | L |
| clearance: | 0.2 | L/h |
| other parameters in model implementation | ||
Technetium (99mTc) stannous agent labelled cells are autologous blood cells (usually red blood cells or leukocytes) that are labelled ex vivo with a technetium-99m stannous agent. Used as a radiopharmaceutical, they assist in the diagnostic imaging of various conditions such as gastrointestinal bleeding (with labelled red blood cells) or infection/inflammation imaging (with labelled leukocytes). The compound is approved as a diagnostic agent used in nuclear medicine imaging techniques.
Estimated PK parameters for autologous technetium-99m labelled cells in healthy adult subjects based on general radiopharmaceutical pharmacokinetic knowledge; no specific original compartmental PK parameters published for this preparation.